The most widely used 68Ga–based imaging/diagnostic agents are [68Ga]Ga-DOTA-Somatostatin analogues like TOC, TATE or NOC for patients affected by neuroendocrine tumours (NET), and prostate specific membrane antigen [68Ga]68Ga-PSMA for prostate tumours [17,18]. This evidence concerns the gene FOLH1 and prostate neoplasm.